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The aim of this study was to evaluate carotid arterial wall elasticity in type 2 diabetes mellitus (T2DM) with microalbuminuria
by real-time ultrasound elastography. Two hundred and ten T2DM patients were divided into two groups according to levels of
urinary albumin excretion (UAE): T2DM without microalbuminuria (T2DM1 group, 120) and T2DM with microalbuminuria
(T2DM2 group, 90). The right common carotid arteries were examined by real-time ultrasound elastography. The strain ratio
(SR, blood to arterial wall strain ratio) was calculated by dividing the strain value of the blood by that of the carotid arterial wall.
The correlation between SR and general data was analyzed. The mean SR value ± SD of T2DM2 group was signiﬁcantly higher
than that of T2DM1 group (P<0.05). SR was positively and signiﬁcantly correlated with UAE, HbA1c, and systolic blood pressure
(r = 0.456,0.435,0.235, P<0.05 for all). The mean value ± SD of UAE, HbA1c, 2hPG, BMI, and TC of T2DM2 group was signi-
ﬁcantly higher than that of T2DM1 group (P<0.05 for all). In conclusion, there is an association between microalbuminuria and
carotid arterial wall elasticity in T2DM patients.
1.Introduction
The major complication of type 2 diabetes mellitus (T2DM)
is atherosclerosis, and it is the main cause of death in diabe-
tic patients [1–3]. However, the mechanism remains poorly
understood, especially the direct relation between microal-
buminuria and vascular wall elasticity in T2DM. Several
researches studied the relation between arterial stiﬀness
and microalbuminuria in diabetes by pulse wave velocity
(PWV) and echo-tracking technique [4–6]. In this study, we
used real-time ultrasound (US) elastography to evaluate the
elasticity of carotid arterial wall in T2DM with microalbu-
minuria. The real-time US elastography is a newly developed
ultrasound technique which provides an estimation of tissue
stiﬀness. And it became a focus in recent years. The US
elastography has been mainly applied to the studies of breast,
thyroid gland, and prostate [7–9].
2.MaterialsandMethods
2.1. Participants. The study included 210 consecutive
patients of T2DM in the Department of Endocrinology
of 2nd Aﬃliated Hospital of Dalian Medical University
from February 2009 to February 2011. T2DM was diagnos-
ed according to the 1999 World Health Organization criteria.
Type 1 diabetes mellitus, hypertension, history of ischem-
ic heart disease, renal impairment (serum creatinine
>150umol/L), and valvular heart diseases were excluded.
The clinical conditions that could cause transient elevations
in urinary albumin excretion, such as exercise, urinary tract
infection, and febrile illness, were also excluded. According
to the level of urinary albumin excretion (UAE), 210 patients
of T2DM were divided into two groups: T2DM without
microalbuminuria (T2DM1 group, UAE < 30mg/24h; 120
cases, 65 males and 55 females; mean age, 55.33 ± 9.582 International Journal of Endocrinology
years; age range, 27–78 years; diabetes duration, 6 months–
5 years; treatment with diet or oral drugs) and T2DM with
microalbuminuria (T2DM2 group, 30mg/24h < UAE <
300mg/24h; 90 cases, 48 males and 42 females; mean age,
58.89±12.20years;agerange,41–80years;diabetesduration,
6 months–10 years; treatment with diet or oral drugs). The
diagnosis of microalbuminuria was performed on the basis
of one evaluation of UAE. The Ethics Committee of 2nd
AﬃliatedHospitalofDalianMedicalUniversityapprovedthe
study. All patients gave their informed consent to participate
in the study.
2.2. Carotid Artery US Elastography. Carotid artery US elas-
tography was performed using a real-time ultrasound scan-
ner: Hitachi EUB 7500 with a linear 3–15MHz probe
(Hitachi Medical Systems, Tokyo, Japan). The scanner is
equipped with a dedicated software to provide an accurate
measurement of tissue elasticity. B-mode sonographic exam-
inations were performed in transverse and longitudinal
planes of the right carotid with the patients supine.
In B-mode display, a midsection of straight carotid in
longitudinal plane was chosen. The elastographic mode was
performed to show double images of B-mode and elastogra-
phy in the meantime. A rectangular region of interest (ROI)
box covered at least 3 times of diameter of carotid artery.
The probe was placed on the neck with proper pressure. The
probecompressiononthecarotidregionwasstandardizedby
real-timemeasurementdisplayedonanumericalscale(levels
from 1–5). The levels from 2–4 were chosen in our study. It
is important that the level of pressure is maintained constant
throughout the examination. The ultrasound elastographic
images were displayed with diﬀerent color mapping includ-
ing red (softest component), green (intermediate stiﬀness),
and blue (hardest component) according to the diﬀerent
levels of strain. On a representative static image, the relative
strain ratio (SR, blood to carotid arterial wall strain ratio)
was measured. The ﬁrst ROI (A) for the arterial wall strain
was manually drawn and placed in approximate midpoint of
posterior wall of displayed carotid artery. The second ROI
(B) for the blood strain was placed in the center of arterial
cavity. The distance between ROI (A) and ROI (B) should be
almost the same in diﬀerent scannings. SR was calculated by
dividing strain value of the blood by that of carotid arterial
wall. And SR was calculated automatically by an embedded
software in the ultrasound scanner.
A l le x a m i n a t i o n sw e r ep e r f o r m e db yt w oo p e r a t o r s .




was 0.90 for mean SR.
2.3. Laboratory Assays. All laboratory assays were performed
at the Clinical Laboratory Unit of the Second Aﬃliated
Hospital of Dalian Medical University. The following labora-
tory parameters were obtained: total cholesterol (TC), trigly-
ceride (TG), low density lipoprotein (LDL), high den-
sity lipoprotein (HDL), hemoglobin A1c (HbA1c), fasting
plasma glucose (FPG), postprandial 2hours plasma sugar
(2hPG), and urinary albumin excretion (UAE). Serum con-
centrations of TC, TG, LDL, HDL, FBG, and 2hPG were
measured by enzymatic method. HbA1C was measured by
high performance liquid chromatography (BRO-RAD Com-
pany, USA). UAE was obtained by a 24-hour urine col-
lection (by one determination). Body mass index (BMI)
was calculated as weight in kilograms divided by height in
metersquared.Theintra-andinterassaycoeﬃcientsofvaria-
tion of all techniques were less than 5%. Blood pressure
was measured with a standard mercury sphygmomanometer
after at least 10min rest in the sitting position.
2.4.StatisticalAnalysis. ThesoftwareofSPSSversion13.0for
Windows(SPSSInc,IL,USA)wasusedforstatisticalanalysis.
Statistical signiﬁcance between two groups was determined
by Student’s t-test. Continuous variables were expressed as
X ± SD. Pearson correlation was used for correlation ana-
lysis. All tests were performed with P<0.05 considered sta-
tistically signiﬁcant.
3. Results
During the 24-month study period, 210 consecutive T2DM
patients with or without microalbuminuria were screened.
The characteristics of the 210 enrolled patients are shown in
Table 1. The mean SR value ± SD of T2DM2 group (1.56 ±
0.45) was signiﬁcantly higher than that of T2DM1 group
(1.10 ± 0.24, P<0.05) (Figures 1 and 2, Table 1). The mean
values ± SD of 2hPG, BMI, TC, UAE, and HbA1c of T2DM2
group were signiﬁcantly higher than those of T2DM1 group
(P<0.05 for all) (Table 1). There were no signiﬁcant diﬀer-
ence in systolic blood pressure, diastolic blood pressure, TG,
LDL, HDL, FPG between T2DM1 and T2DM2 groups (P>
0.05 for all) (Table 1). In univariate analysis, SR was posi-
tively and signiﬁcantly associated with UAE (r = 0.456, P<
0.05) and HbA1c (r = 0.435, P<0.05), systolic blood pres-
sure (r = 0.235, P<0.05).
4. Discussion
The real-time US elastography is a newly developed dynamic
technique which can obtain information on tissue stiﬀness
and strain noninvasively [10, 11]. It can evaluate the degree
of distortion of a tissue under an external force on the basis
that the softer tissues deform easier than the harder one. In
term of strain, strain represents the degree of deformation.
Therefore, the soft tissue shows larger strain than the stiﬀ
tissue. In real-time US elastography, the strain images are
showed in a color map. The color scale includes red, green,
and blue colors. The red represents greatest elastic strain
which is the softest, and the blue represents no strain which
is the hardest. The green represents the mid level of strain. In
our study, we used the strain ratio to reﬂect carotid arterial
wall elasticity. The larger the SR is, the poorer the elasticity
is.
The present study has clearly shown that the mean
SR value ± SD of T2DM patients with microalbuminuria
was signiﬁcantly higher than that in T2DM patients with
normoalbuminuria. And SR was positively and signiﬁcantlyInternational Journal of Endocrinology 3
Table 1: Characteristics of two groups.
Characteristic T2DM1 group (n = 120) T2DM2 group (n = 90) P value
Systolic blood pressure (mmHg) 129.8 ±15.5 130 ±16.5 0.780
Diastolic blood pressure (mmHg) 81.8 ±9.38 0 .7 ±9.5 0.830
2hPG mmol/L 9.42 ±4.05 12.93 ±4.80 0.008
FPG mmol/L 9.43 ±3.66 9.35 ±4.07 0.940
BMI kg/m2 25.66 ±4.08 27.80 ±3.22 0.029
TC mmol/L 4.88 ±1.17 5.51 ±0.87 0.024
TG mmol/L 1.68 ±1.27 2.21 ±1.36 0.125
LDL mmol/L 3.20 ±1.20 3.30 ±0.80 0.584
HDL mmol/L 0.99 ±0.27 0.98 ±0.24 0.897
HbA1c % 8.36 ±2.33 9.45 ±1.86 0.046
UAE mg/24 h 12.22 ±8.57 96.55 ±64.67 0.000
SR 1.10 ±0.24 1.56 ±0.45 0.000
Figure 1: Longitudinal carotid artery image obtained in T2DM1
g r o u po nr e a l - t i m eU Se l a s t o g r a p h y .T h el e f ti m a g es h o w st h e
elastographic image in diﬀerent colors representing diﬀerent levels
of strain. The right image shows the positions of ROI (A) and ROI
(B), and the strain ratio (blood to carotid arterial wall strain ratio)
as 1.44, calculated as the blood strain (B, 0.46%) divided by the
arterial wall strain (A, 0.32%).
associated with UAE. The results suggested that microalbu-
minuria in T2DM may have an eﬀect on elasticity of carotid
arterial wall. Maybe there is a close relationship between
atherosclerosis and diabetic nephropathy. Our ﬁndings were
in accordance with the previous studies which evaluated the
arterial wall elasticity in T2DM patients with microalbumin-
uria by pulse wave velocity (PWV) and echo-tracking tech-
nique [6–8]. But the mechanism underlying the relationship
between microalbuminuria and atherosclerosis in T2DM
patients is still unknown; in particular, little is known on the
direct relationship between microalbuminuria and carotid
arterial wall properties. There were reports that increased
UAER could reﬂect a generalized vascular dysfunction which
was caused by structural alterations, such as a reduction in
the density of heparan sulfate-proteoglycan (HS-PG) and/or
the sulphation of HS within the extracellular matrix of the
glomerular basement membrane and vascular wall [12, 13].
Figure 2: Longitudinal carotid artery image obtained in T2DM2
g r o u po nr e a l - t i m eU Se l a s t o g r a p h y .T h el e f ti m a g es h o w st h e
elastographic image in diﬀerent colors representing diﬀerent levels
of strain. The right image shows the positions of ROI (A) and ROI
(B), and the strain ratio (blood to carotid arterial wall strain ratio)
as 2.40, calculated as the blood strain (B, 0.44%) divided by the
arterial wall strain (A, 0.19%).
HS-PG is synthesized in endothelial and myomedial cells. It
is a normal component of glomerular basement membrane,
endothelial vascular surface, and basement membrane of
vascular smooth muscle cells. Furthermore, many proteins,
such as lipoprotein lipase, tissue factor pathway inhibitor,
platelet factor 4, and antithrombin III, are anchored to
the vascular wall through interaction with the chains of
HS-PG, which may enhance albuminuria and processes
involved in atherogenesis [14–16]. Stehouwer et al. [17]
found that microalbuminuria was linearly associated with
impaired endothelium-dependent, ﬂow-mediated vasodila-
tion in elderly individuals without and with diabetes. It is
possible that endothelial leakiness, as reﬂected by UAE, is in
part a primary and possibly genetically determined vascular
risk factor or that it mirrors the endothelial dysfunction fea-
turing the atherosclerotic process or arises from the action of
yet unknown risk factors [18].4 International Journal of Endocrinology
In the present study, the result showed that the value of
HbA1c in T2DM patients with microalbuminuria was signi-
ﬁcantly higher than that in T2DM patients with normoalbu-
minuria. And SR was positively and signiﬁcantly associated
with HbA1c. HbA1c maybe play an important role in
the relationship between carotid arterial wall elasticity and
microalbuminuria.HbA1ccanaccuratelyreﬂectlonger-term
glycemia. Clinically, HbA1c is regarded as a useful method
of screening and diagnosing diabetes. And HbA1c has been
accepted as the best marker for diabetic microvascular com-
plications [19]. Moreover, HbA1c is associated closely with
advanced glycation end products (AGEs) [20]. The previous
study showed that AGEs are widespread in the diabetic vas-
cular system and contribute to the development of athe-
rosclerosis [21]. AGEs contribute to many microvascular
and macrovascular complications through the formation of
bridgings between molecules in the basement membrane of
the extracellular matrix by joining the receptor for advanced
glycation end products (RAGE). Concerning microalbumin-
uria, it was reported that the accumulation of AGEs in the
glomerular and tubulointerstitial spaces correlates with the
severity of diabetic nephropathy [22].
Our study has its limitations. First, some T2DM patients
have already been treated for diabetes and hyperlipidemia
which may lead to inaccuracy of the results. Second, in
the process of real-time US elastography, in order to get a
relevant conclusion, either high or overly low pressure on
the skin must be avoided. We chose the pressure of mode-
rate degree according to a visual indicator displayed by
a numerical scale on the screen. Nevertheless, the error
induced by pressure cannot be avoided completely.
5. Conclusion
Our data show that there is an association between microal-
buminuria and carotid arterial wall elasticity in T2DM
patients.Thedecreasedarterialwallelasticitycausedbyathe-
rosclerosis may be related to the progression of diabetic
nephropathy in T2DM patients. Real-time US elastography
can evaluate carotid arterial wall elasticity in T2DM with
microalbuminuria accurately and eﬃciently. However, larger
and further studies are needed to conﬁrm our results and
hypothesis.
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